← Evidence library

BIB_183

Wolchok JD et al. 10-year OS outcomes in metastatic melanoma treated with nivolumab + ipilimumab or nivolumab alone (CheckMate-067 follow-up). NEJM 2025. ~43% 10-yr OS combination arm; durable plateau confirmed. [Tasks: 18] Tier: 1 Grade: A Retrieved: 2026-05-07

Evidence grade

A

Tier

1

Cited by tasks

18

Identifiers

—

Full extracted findings & patient-implication analysis: bibliography/BIB_183/findings.md (research corpus). This page is a short context summary — not individualised medical advice.